Copyrigt and liscencing

Copyright and Licensing — ACE Journal of Addiction (ACEJA)

Upon submission of a manuscript, authors are required to complete and sign a publication licensing agreement, which shall take effect only upon acceptance of the manuscript for publication following peer review. If the manuscript is not accepted, the agreement is void and confers no rights.

ACE Journal of Addiction (ACEJA) follows an Open Access publishing model, ensuring that all published articles are freely accessible to readers worldwide without subscription barriers.

Under this policy:

  • Authors retain the copyright of their published work.
  • Authors grant the journal the right to publish, archive, distribute, and promote the article.
  • Published articles are made available under a Creative Commons license.

Recommended License

Unless otherwise specified, articles will be published under the:

Creative Commons Attribution License (CC BY 4.0)

This license permits others to:

  • Read
  • Download
  • Copy
  • Share
  • Distribute
  • Reproduce
  • Adapt the work

for lawful purposes, provided appropriate credit is given to the original author(s) and the journal.

Authors are responsible for ensuring:

  • The submitted work is original
  • Proper permissions are obtained for copyrighted third-party materials (figures, tables, images, etc.)
  • The manuscript does not infringe upon any intellectual property rights

Third-Party Content

If authors include copyrighted material from other sources, they must obtain written permission from the original copyright holder before submission.

Patient and Participant Material

Copyright and licensing under this policy apply to the manuscript text, figures, tables, and other scholarly content created by the author(s). They do not extend to any patient-identifiable material — including clinical photographs, case histories, direct quotations from participants, or other information that could identify an individual.

Authors including such material must:

  • Obtain separate, specific written informed consent from the patient or participant (or their legal guardian, where applicable) for publication, distinct from consent to participate in the underlying study
  • Ensure all identifying details are removed or adequately anonymized wherever clinical relevance permits
  • Retain the signed consent documentation and provide it to the editorial office upon request

Publication of such material remains subject to the confidentiality and human-subjects provisions described in the journal's Ethical Publishing Standards, regardless of the copyright license under which the article itself is published.